Investment Trusts

Fidelity Emerging Markets Ltd

GG00B4L0PD47:GBX

Fidelity Emerging Markets Ltd

  • Price (GBX)687.00
  • Today's Change-1.00 / -0.15%
  • Shares traded-1.00
  • 1 Year change18.86%
  • Beta0.7724
Data delayed at least 20 minutes, as of May 02 2024 14:59 BST.
More ▼
Total returns on £1000
1Y
Fund/benchmarkChange
PriceFidelity Emerging Markets Ltd (Ordinary Share)+22.31%
NAVFidelity Emerging Markets Ltd (Ordinary Share)+17.34%
Morningstar's BenchmarkMSCI EM TR--

Key statistics

As of last trade Fidelity Emerging Markets Ltd (GG00B4L0PD47:GBX) traded at 687.00, -7.20% below its 52-week high of 740.30, set on Mar 26, 2024.
52-week range
Today
568.10Jul 10 2023740.30Mar 26 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding76.53m
Market cap527.95m GBP
Total assets594.37m GBP
Total expense ratio0.81%
High697.00
Low679.40
Previous close688.00
Average volume37.78k
YTD Change+11.51%
Beta0.7724
Diluted NAV (est)778.49
Diluted NAV (last pub)776.81
Premium/Discount-12.21%
Net Gearing0.00%
Annual div (ADY)15.31 GBX
Annual div yield (ADY)2.23%
Div ex-dateNov 16 2023
Div pay-dateDec 15 2023
Data delayed at least 20 minutes, as of May 02 2024 14:59 BST.
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.